Lickliter J

No ORCID on file · 1 paper in corpus · active 2022
2022
Pituitary ·doi:10.1007/s11102-021-01201-z

PurposeEvaluate the pharmacodynamics, pharmacokinetics, and safety of paltusotine, an orally bioavailable, nonpeptide, somatostatin receptor subtype 2 (SST2) agonist being developed for the treatment of acromegaly and neuroendocrine tumors.…